RPID 📈 Rapid Micro Biosystems - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US75340L1044
RPID: Microbial Contamination Detection Systems, Laboratory Informatics Software
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts. Web URL: https://www.rapidmicrobio.com
Additional Sources for RPID Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
RPID Stock Overview
Market Cap in USD | 45m |
Sector | Healthcare |
Industry | Medical Devices |
GiC Sub-Industry | Wireless Telecommunication Services |
IPO / Inception | 2021-07-15 |
RPID Stock Ratings
Growth 5y | -75.4% |
Fundamental | -47.2% |
Dividend | - |
Rel. Strength Industry | -88.3 |
Analysts | 5/5 |
Fair Price Momentum | 0.63 USD |
Fair Price DCF | - |
RPID Dividends
No Dividends PaidRPID Growth Ratios
Growth Correlation 3m | 53.7% |
Growth Correlation 12m | 2.9% |
Growth Correlation 5y | -91.5% |
CAGR 5y | -60.09% |
CAGR/Mean DD 5y | -0.73 |
Sharpe Ratio 12m | 0.26 |
Alpha | -32.02 |
Beta | 1.33 |
Volatility | 100.46% |
Current Volume | 115.7k |
Average Volume 20d | 53.3k |
What is the price of RPID stocks?
As of December 22, 2024, the stock is trading at USD 0.90 with a total of 115,704 shares traded.
Over the past week, the price has changed by -1.96%, over one month by -9.09%, over three months by +15.07% and over the past year by +4.17%.
As of December 22, 2024, the stock is trading at USD 0.90 with a total of 115,704 shares traded.
Over the past week, the price has changed by -1.96%, over one month by -9.09%, over three months by +15.07% and over the past year by +4.17%.
Is Rapid Micro Biosystems a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Rapid Micro Biosystems (NASDAQ:RPID) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -47.15 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RPID as of December 2024 is 0.63. This means that RPID is currently overvalued and has a potential downside of -30%.
Probably not. Based on ValueRay Fundamental Analyses, Rapid Micro Biosystems (NASDAQ:RPID) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -47.15 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RPID as of December 2024 is 0.63. This means that RPID is currently overvalued and has a potential downside of -30%.
Is RPID a buy, sell or hold?
Rapid Micro Biosystems has received a consensus analysts rating of 5.00. Therefor, it is recommend to buy RPID.
Rapid Micro Biosystems has received a consensus analysts rating of 5.00. Therefor, it is recommend to buy RPID.
- Strong Buy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecast for RPID stock price target?
According to ValueRays Forecast Model, RPID Rapid Micro Biosystems will be worth about 0.7 in December 2025. The stock is currently trading at 0.90. This means that the stock has a potential downside of -22.22%.
According to ValueRays Forecast Model, RPID Rapid Micro Biosystems will be worth about 0.7 in December 2025. The stock is currently trading at 0.90. This means that the stock has a potential downside of -22.22%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 8 | 788.9% |
Analysts Target Price | 5.9 | 553.3% |
ValueRay Target Price | 0.7 | -22.2% |